Accelerated Vascular Aging as a Possible Mechanism of Troponin I Release in the Absence of Clinically Manifested

G A Alanis1, P Boutouyrie2, M Abouqateb1

  • 1Integrative Epidemiology of Cardiovascular Disease Université Paris Cité, INSERM U970 Paris France.

Insights

Vascular aging, specifically arteriosclerosis and atherosclerosis, is linked to higher troponin I levels in healthy adults. These vascular changes may contribute to troponin release even without diagnosed cardiovascular disease.

Area of Science:

  • Cardiology
  • Vascular Biology
  • Biomarkers

Background:

  • Vascular aging is a spectrum of changes in arteries.
  • Ultrasensitive cardiac troponin I (us-cTnI) is a biomarker for cardiac injury.
  • The relationship between vascular aging patterns and us-cTnI in disease-free individuals is not fully understood.

Purpose of the Study:

  • To investigate the association between distinct clusters of vascular aging manifestations and ultrasensitive cardiac troponin I levels.
  • To determine if specific vascular aging patterns predict elevated troponin I in individuals without cardiovascular disease.

Main Methods:

  • Cross-sectional analysis of 8722 participants from the Paris Prospective Study III.
  • Vascular aging assessed using carotid artery echotracking for structural and functional parameters.
  • Hierarchical clustering identified vascular aging clusters; multinomial regression analyzed associations with cardiac troponin I quintiles.

Main Results:

  • Three vascular aging clusters were identified: healthy, arteriosclerosis-dominant, and atherosclerosis-dominant.
  • Both arteriosclerosis and atherosclerosis clusters showed a graded positive association with cardiac troponin I levels.
  • Individuals in the atherosclerosis cluster had significantly higher odds of being in the highest troponin I quintile (aOR 2.66) compared to the healthy cluster.

Conclusions:

  • Arteriosclerosis and atherosclerosis represent distinct vascular aging phenotypes.
  • These vascular aging manifestations may contribute to troponin I release in the absence of clinical cardiovascular disease.
  • Findings suggest vascular health is a key determinant of circulating troponin levels.
Abstract

Related Concept Videos

Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
73
Nitric Oxide Signaling Pathway01:28

Nitric Oxide Signaling Pathway

Nitric oxide (NO), an inorganic gas, acts as a potent second messenger in most animal and plant tissues. NO diffuses out of the cells that produce it and enters the neighboring cells to generate a downstream response. NO synthase (NOS) catalyzes NO production by the deamination of the amino acid arginine. There are three isoforms of NOS. Endothelial cells have endothelial NOS (eNOS), nerve and muscle cells have neuronal NOS (nNOS), and macrophages produce inducible NOS (iNOS) upon exposure...
4.9K
Smooth Muscle Contraction01:25

Smooth Muscle Contraction

Smooth muscle contraction is a complex process vital for various bodily functions, from maintaining blood vessel tension to facilitating the movement of food through the digestive tract. Unlike striated muscles, smooth muscle contraction begins more slowly and lasts longer.
The onset of contraction is triggered by an increase in calcium ions within the sarcoplasm, similar to the process in striated muscle. However, smooth muscles have a relatively smaller reservoir of the sarcoplasmic...
2.2K
Cross-bridge Cycle01:26

Cross-bridge Cycle

As muscle contracts, the overlap between the thin and thick filaments increases, decreasing the length of the sarcomere—the contractile unit of the muscle—using energy in the form of ATP. At the molecular level, this is a cyclic, multistep process that involves binding and hydrolysis of ATP, and movement of actin by myosin.
116.4K
Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
1.4K
Relaxation of Skeletal Muscles01:29

Relaxation of Skeletal Muscles

The period of muscle contraction primarily influences the duration of stimulation at the neuromuscular junction (NMJ), the presence of free calcium ions in the sarcoplasm, and the availability of energy or ATP to support contractions.
When an action potential reaches the axon terminal, it depolarizes the membrane and opens voltage-gated sodium channels. Sodium ions enter the cell, further depolarizing the presynaptic membrane. This depolarization causes voltage-gated calcium channels to open....
2.9K